Is a Glioma (Glial Tumor) Benign?

Glioma (glial tumor), which is among the diseases of the brain and nervous system, is a type of tumor that originates from glial cells, the cells that support nerve cells. These tumors can show different characteristics in each patient; some progress slowly and are benign, while others may grow rapidly and behave malignantly. Prof. Dr. Ömür Günaldı, who has many years of experience in neurosurgery, emphasizes that correct staging of gliomas and creating a personalized treatment plan are of vital importance.

What Is Glioma (Glial Tumor)?

Glioma takes its name from glial cells, the supportive cells found in the brain. These cells support neurons, regulate nerve transmission, and maintain the integrity of brain tissue. When glial cells multiply abnormally, a glial tumor or glioma develops.

Prof. Dr. Ömür Günaldı states that gliomas should be classified not only according to the location of the tumor but also according to their cellular structure and growth rate.

Types of Glial Cells

There are three main types of glial cells in the brain:

Astrocytes: Maintain metabolic balance in the brain.

Oligodendrocytes: Form the myelin sheath that protects nerve fibers.

Ependymal cells: Involved in the circulation of cerebrospinal fluid.

Depending on which of these cells proliferates uncontrollably, different types of gliomas such as astrocytoma, oligodendroglioma, or ependymoma may develop.

Prof. Dr. Ömür Günaldı emphasizes that treatment approaches vary depending on the cellular origin of the tumor in each patient.

Are Gliomas Benign or Malignant?

Gliomas are generally divided into two main categories:

Benign gliomas
Malignant gliomas

Benign Gliomas

Benign gliomas usually grow slowly and spread to surrounding tissues in a limited manner. If detected early, these tumors can often be completely removed through surgery.

Prof. Dr. Ömür Günaldı notes that surgical success rates are quite high in benign gliomas and that patients can live healthy lives for many years after treatment.

Examples of benign gliomas include:

Low-grade astrocytomas (Grade I–II)
Pilocytic astrocytoma
Subependymoma

These tumors generally do not metastasize to other parts of the body.

Malignant Gliomas

Malignant gliomas are aggressive tumors that grow rapidly. They tend to spread into surrounding brain tissue and may recur even after surgery.

Prof. Dr. Ömür Günaldı explains that high-grade gliomas (Grade III–IV) require close follow-up and multidisciplinary treatment.

Examples of malignant gliomas include:

Anaplastic astrocytoma (Grade III)
Glioblastoma multiforme (GBM, Grade IV)

In these tumors, genetic mutations and disruptions in cellular signaling pathways are more pronounced.

How Can We Tell If a Glioma Is Benign or Malignant?

To determine whether a glioma is benign or malignant, clinical evaluation, imaging findings, and biopsy results must be assessed together.

Prof. Dr. Ömür Günaldı emphasizes that diagnosis cannot rely solely on MRI findings; definitive diagnosis requires pathological examination at the cellular level.

Diagnostic Methods

Magnetic Resonance Imaging (MRI): Determines the tumor's location, size, and spread.

MR Spectroscopy: Analyzes chemical changes within tumor tissue.

Biopsy: The most important method for definitive diagnosis. A tissue sample is examined under a microscope.

Genetic Tests: Genetic markers such as IDH mutation or 1p/19q deletion are evaluated. These tests provide important clues about whether the tumor is benign or malignant.

Glioma Grades (WHO Classification)

Gliomas are complex brain tumors that can appear in many structural forms. Therefore, they do not progress the same way in every patient.

The World Health Organization (WHO) classifies gliomas into four grades based on cellular structure, growth rate, and spread to surrounding tissues.

Prof. Dr. Ömür Günaldı emphasizes that this classification is extremely important in determining treatment plans and predicting patient prognosis.

Grade I Gliomas

Grade I gliomas are generally considered benign. Cells divide slowly, the tumor does not spread to surrounding tissues, and it remains within clear boundaries.

These tumors are most commonly seen in childhood and young adulthood. They can often be completely removed through surgery.

Prof. Dr. Ömür Günaldı states that early diagnosis in Grade I gliomas is extremely important and that patients may live healthy lives for many years after complete removal.

Radiotherapy or chemotherapy is usually not necessary at this stage.

Grade II Gliomas

Grade II gliomas are low-grade tumors but have the potential to progress over time. Although cell proliferation is relatively slow, structural changes may cause them to transform into higher-grade tumors.

These tumors may spread slightly into brain tissue, which means microscopic tumor remnants may remain after surgery.

Prof. Dr. Ömür Günaldı explains that Grade II gliomas require regular imaging follow-ups and that radiotherapy or chemotherapy may sometimes be added to surgical treatment.

Grade III Gliomas

Grade III gliomas are considered malignant tumors. Cells multiply more rapidly, tend to spread into surrounding brain tissue, and carry a higher risk of recurrence.

At this stage, tumors are often seen as aggressive subtypes such as anaplastic astrocytoma.

Prof. Dr. Ömür Günaldı states that combining radiotherapy and chemotherapy after surgery can extend survival and slow disease progression.

Grade IV Gliomas

Grade IV gliomas, known as Glioblastoma Multiforme (GBM), are the most aggressive and malignant brain tumors.

Cells divide very rapidly, spread easily to healthy tissues, and have a high risk of recurrence despite treatment.

In these tumors, surgery alone is not sufficient. Radiotherapy, chemotherapy, and sometimes targeted therapies or immunotherapy are required.

Prof. Dr. Ömür Günaldı emphasizes that the main goal of treatment in glioblastoma patients is to prolong survival and improve quality of life.

Treatment of Glioma

Surgical Treatment

Surgery is usually the first treatment option for gliomas. The goal is to remove as much of the tumor as possible.

Prof. Dr. Ömür Günaldı explains that with advanced microscopic and neuronavigation techniques, tumors can be removed while minimizing damage to healthy brain tissue.

In benign gliomas, surgery alone is often sufficient.

Radiotherapy

Radiotherapy is applied after surgery to eliminate remaining microscopic tumor cells.

Prof. Dr. Ömür Günaldı states that radiotherapy significantly improves survival in high-grade gliomas.

Chemotherapy

Drugs such as temozolomide are commonly used in malignant gliomas. In many cases, chemotherapy is combined with radiotherapy to delay tumor recurrence.

Targeted Therapy and Immunotherapy

In recent years, genetic profiling has allowed the development of targeted therapies for certain glioma types.

Prof. Dr. Ömür Günaldı states that these treatments represent promising advances in personalized medicine.

Survival and Prognosis

Whether a glioma is benign or malignant directly affects patient survival.

In benign gliomas, survival can exceed 10 years after treatment.

In malignant gliomas, average survival may range between 12 and 36 months.

However, Prof. Dr. Ömür Günaldı emphasizes that early diagnosis and multidisciplinary treatment approaches can significantly extend survival.

Nutrition and Lifestyle in Glioma

Nutrition plays an important role in supporting the immune system during brain tumor treatment.

Prof. Dr. Ömür Günaldı recommends a balanced diet rich in antioxidants and low in refined sugar for glioma patients.

Nutritional Recommendations

Consume plenty of fruits and vegetables

Eat fish and walnuts rich in omega-3 fatty acids

Avoid refined carbohydrates

Include antioxidant sources such as green tea, turmeric, and olive oil

Drink adequate amounts of water

Regular exercise, stress management, and adequate sleep also support the treatment process.

Risk of Recurrence

Even benign gliomas may transform into malignant forms over time.

Prof. Dr. Ömür Günaldı states that regular MRI follow-ups after surgery are essential.

High-grade gliomas have a higher recurrence rate, which is why patients should be monitored by a multidisciplinary medical team.

Importance of Early Diagnosis

Early diagnosis directly affects treatment success.

Symptoms such as headaches, balance problems, vision changes, personality changes, or seizures should not be ignored.

Prof. Dr. Ömür Günaldı emphasizes that early neurological evaluation in patients with these symptoms can significantly extend survival.

Glioma (glial tumor) may show a benign course in some cases, but the tumor type, cellular structure, and stage are determining factors.

While complete cure may be possible in benign gliomas through surgery, malignant tumors often require combined treatments.

With extensive experience in neurosurgery, Prof. Dr. Ömür Günaldı emphasizes that the most appropriate approach is a personalized treatment plan tailored to each glioma patient.